HomeREGULATORY
REGULATORY

Mogamulizumab Gets Orphan Status for HTLV-1-Associated Myelopathy
(Dec.22.2017)

The Ministry of Health, Labor and Welfare (MHLW) on December 21 granted orphan drug designation for Kyowa Hakko Kirin’s mogamulizumab for the treatment of HTLV-1-associated myelopathy ...
(LOG IN FOR FULL STORY)

News Calendar